Home › Cancro ai polmoni › Illinois › Cicero
Studi clinici su Cancro ai polmoni a Cicero, IL
17 studi su Cancro ai polmoni cercano partecipanti presso sedi a Cicero e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
In reclutamentoFase 3
- Edward Hines Jr VA Hospital, Hines · a 4 mi di distanza
- Advocate Christ Medical Center, Oak Lawn · a 9 mi di distanza
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- OSF Little Company of Mary Medical Center, Evergreen Park · a 9 mi di distanza
- Advocate Christ Medical Center, Oak Lawn · a 9 mi di distanza
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
In reclutamentoFase 3
- Advocate Christ Medical Center, Oak Lawn · a 9 mi di distanza
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
In reclutamentoFase 3
- Northwestern Medicine Oak Brook, Oak Brook · a 9 mi di distanza
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
In reclutamentoFase 3
- Northwestern Medicine Oak Brook, Oak Brook · a 9 mi di distanza
Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
In reclutamentoFase 2
- Hope and Healing Clinical Research, Hinsdale · a 10 mi di distanza
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
In reclutamentoFase 3
- Hope and Healing Cancer Services, Hinsdale · a 10 mi di distanza
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
In reclutamentoFase 2
- Hope and Healing Clinical Research, Hinsdale · a 10 mi di distanza
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
In reclutamentoFase 3
- Advocate Christ Medical Center, Oak Lawn · a 9 mi di distanza
- Hope and Healing Cancer Services, Hinsdale · a 10 mi di distanza
- Endeavor Health, Elmhurst · a 10 mi di distanza
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
In reclutamentoFase 3
- Affiliated Oncologists, LLC, Chicago Ridge · a 10 mi di distanza
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
In reclutamentoFase 3
- Advocate Christ Medical Center, Oak Lawn · a 9 mi di distanza
- Advocate High Tech Medical Park, Palos Heights · a 12 mi di distanza
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
In reclutamentoFase 2
- Rush MD Anderson Cancer Center at Rush Oak Park, Oak Park · a 3 mi di distanza
- Edward Hines Jr VA Hospital, Hines · a 4 mi di distanza
- Loyola University Medical Center, Maywood · a 5 mi di distanza
- e altri 2
MYLUNG Consortium Part 3: Observational Study
In reclutamentoStudio osservazionale
- Affiliated Oncologists, LLC, Chicago Ridge · a 10 mi di distanza
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
In reclutamentoFase 2
- Edward Hines Jr VA Hospital, Hines · a 4 mi di distanza
- Loyola University Medical Center, Maywood · a 5 mi di distanza
- Northwestern Medicine Oak Brook, Oak Brook · a 9 mi di distanza
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
In reclutamentoFase 2/3
- Loyola University Medical Center, Maywood · a 5 mi di distanza
- Northwestern Medicine Oak Brook, Oak Brook · a 9 mi di distanza
- Advocate Christ Medical Center, Oak Lawn · a 9 mi di distanza
- e altri 2
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
In reclutamento
- Edward Hines Jr. VA Hospital, Hines, IL, Hines · a 4 mi di distanza
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
In reclutamentoStudio osservazionale
- Advocate Christ Medical Center, Oak Lawn · a 9 mi di distanza
- Advocate Outpatient Center - Oak Lawn, Oak Lawn · a 9 mi di distanza
Studi su Cancro ai polmoni in altre città
- Houston, TX78 studi
- Boston, MA62 studi
- New York City, NY60 studi
- Los Angeles, CA45 studi
- Washington, DC41 studi
- Arlington, VA41 studi
- Chicago, IL41 studi
- Nashville, TN40 studi
- Baltimore, MD40 studi
- St. Louis, MO39 studi
- Columbus, OH37 studi
- Philadelphia, PA36 studi
Altri studi a Cicero
- Cancro del polmone non a piccole cellule24 studi
- Cancro alla prostata14 studi
- Cancro (tutti i tipi)13 studi
- Leucemia mieloide acuta11 studi
- Cancro al seno11 studi
- Cancro colorettale10 studi
- Cancro della vescica8 studi
- Cancro metastatico7 studi
- Melanoma7 studi
- Malattie cardiovascolari7 studi
- Linfoma di Burkitt6 studi
- Carcinoma a cellule squamose della testa e del collo6 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.